Moderna to launch trials of new booster vaccine that targets South African Covid variant
The Boston-based biotech has already shipped the raw materials to the US National Institutes of Health, which helped the firm study its first jab, to start human trials.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news
More News: African Health | Biotechnology | Health | National Institutes of Health (NIH) | South Africa Health | Study | Vaccines